Gaba alpha receptors mediate inhibition of T cell responses
US6350769B1 · kind B1 · utility
9Cited by
3References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 24, 2000 |
| Grant date | Feb 26, 2002 |
| Priority date | — |
| Expiry date | Feb 24, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/58
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides new methods for modulating immune responses. The methods are based on the discovery that GABAA receptors are present on peripheral lymphocytes. Thus, GABA agonists and antagonists can be used to modulate immune responses.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.